Press releases
- BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
- BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
- BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
- BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS
- LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION
- SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex™ SYSTEM
- BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT
More ▼
Key statistics
As of last trade, Bio-Techne Corp (TE1:FRA) traded at 64.00, 29.55% above the 52 week low of 49.40 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 64.00 |
---|---|
High | 64.00 |
Low | 64.00 |
Bid | 65.00 |
Offer | 65.50 |
Previous close | 64.00 |
Average volume | 78.33 |
---|---|
Shares outstanding | 157.19m |
Free float | 155.66m |
P/E (TTM) | 50.08 |
Market cap | 10.91bn USD |
EPS (TTM) | 1.39 USD |
Annual div (ADY) | 0.2967 EUR |
---|---|
Annual div yield (ADY) | 0.46% |
Div ex-date | Feb 09 2024 |
Div pay-date | Feb 26 2024 |
Data delayed at least 15 minutes, as of Mar 28 2024 08:37 BST.
More ▼